A phase I trial of sequential administration of Triapine (3-aminopyridine-2-carboxaldehyde) [OCX 0191] followed by fludarabine in adults with relapsed and refractory leukemias and myelodysplasias.
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2010
At a glance
- Drugs Fludarabine; OCX 191
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 09 Sep 2005 New trial record.